Quantum Si Inc (QSI) Opciones

$QBTS A very good Quantum share that has fought its way from -11% into the green and why doesn't $QSI follow suit = $QSI should finally start to rise, nothing has happened for three days, although $QSI is also in the quantum range ?

time to moving up

bounce time now

QSI HOLD INTO OPEN

QSI BIG GAPPA

QSI 2.01 TRIGGER SENDS THIS TO 2.33

QSI GET READY TO ROCK MONDAY..1.25 SUPPORT CAME IN

Yes. Crushed it at Yale!

Jonathan Rothbaum... very smart man

QSI: Second 'SCALP' routine looming!!! (Take a tip from our 'Native American' brothers --- which can be applied to Wall Street too!!!)

QSI: Institutional Ownership 48.13%

Active Positions | Holders | Shares
Increased Positions | 44 | 8,095,138
Decreased Positions | 44 | 2,903,668
Held Positions | 32 | 48,087,303
Total Institutional Shares | 120 | 59,086,109

https://www.nasdaq.com/market-activity/stocks/qsi/institutional-holdings

$QSI

QSI: Sits at the TOP of both of the following (very influential) soaring-stocks LISTS (ignore that one at top of the BARCHART list):
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
https://eresearch.fidelity.com/eresearch/goto/landing.jhtml

Load zone

I have a low bid in, in case I get lucky.
Then, I'll be late and lucky!

QSI: MANY (distinct) news items today!! (See below, if ya have not already read them.)
https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html
https://finance.yahoo.com/news/avantor-distribute-quantum-si-next-123000544.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

Halted like said

Boom 🤩 That's a nice green candle! 💹

=================

Other news today:

Quantum-Si and Planet Innovation to Partner on Proteus™

Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si's novel proteomics platform, Proteus™.

Planet Innovation has a team of over four hundred people with expertise across design, development and manufacturing of scientific instrumentation and medical devices. Currently, Planet Innovation serves as the contract manufacturer for Quantum-Si's Platinum® Pro instrument, set to debut in the first half of 2025. Through this expanded partnership, Planet Innovation will support the development of Quantum-Si's Proteus instrument and serve as the contract manufacturing partner to ensure a seamless transition from development into commercialization.

"We are thrilled to expand our partnership with Planet Innovation and leverage their global scale and expertise to accelerate the development and commercialization of Proteus," said Jeff Hawkins, President and CEO of Quantum-Si. "We believe that partnering with Planet Innovation will allow us to deliver this novel instrument to the market on a timeline of under two years."

"Planet Innovation is proud to support Quantum-Si in developing their new proteomics platform. We have a large, established team with a proven track record in developing world-first life science platforms that are disruptive, compliant and commercialized in record time. We are excited to work side-by-side with the Quantum-Si team in making proteomics more accessible to researchers, scientists and clinicians to ultimately improve human health," said Stuart Elliott, CEO and co-founder of Planet Innovation.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://www.tmcnet.com/usubmit/2024/11/20/10109022.htm

https://planetinnovation.com/

=================

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform

Business Wire
Wed, November 20, 2024

Sets stage for advanced scientific discovery of new diagnostic biomarkers and treatments for disease

BRANFORD, Conn. & BLOOMINGTON, Minn., November 20, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si’s next-generation platform designed to transform proteomic research. The expanded collaboration will develop the consumable for Proteus that will enable simultaneous large factor, protein sequencing with unparalleled accuracy.

Quantum-Si and SkyWater began partnering in 2021 on the first-generation Platinum® platform and announced transition to support production in the second quarter of 2024. SkyWater will continue to supply the consumables for the Platinum Pro product as the two companies expand their engagement to support commercialization of Proteus.

This cutting-edge solution is set to redefine proteomics with unprecedented output per sample, application flexibility and automation. By combining Quantum-Si’s expertise in biotechnology with SkyWater’s Technology as a Service (TaaS) manufacturing capabilities, the collaboration is poised to drive significant advancements in protein sequencing and to the field of proteomics.

"We’re pleased to build on past success together and move into this next product development program with momentum to drive the innovations for this revolutionary proteomics platform," said Ross Miller, SVP Commercial and A&D Business, SkyWater Technology. "This collaboration underscores SkyWater’s commitment to enabling transformative technologies that have the potential to reshape industries and improve lives."

"We are excited to expand our relationship with SkyWater around Platinum, and to apply the learnings and their unique capabilities to our next platform innovation," said Jeff Hawkins, President and CEO of Quantum-Si. "SkyWater’s manufacturing expertise and commitment to innovation make them an ideal partner as we work to commercialize this game-changing platform. With Platinum, we were the first to bring Next-Generation Protein Sequencing™ to researchers globally and we believe our new technology will enable us to further extend our leadership position in protein sequencing and allow us to extend our technology into other areas of proteomics."

Leveraging its custom process development and robust manufacturing capabilities, SkyWater enables the unique technological needs of microfluidic biomedical devices from proof of concept to final qualification. Embracing a TaaS model, SkyWater facilitates early collaboration with system engineers and device designers, developing technology within a production environment. This approach expedites time-to-market, ensures quality from inception, and seamlessly scales to meet volume production demands.

SkyWater holds certification to the ISO 13485 Quality Standard for Medical Devices, affirming its ability to support the design, development, and fabrication of biomedical applications.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

https://www.skywatertechnology.com/

$QSI

Halted up ! Yahoo!!

Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA

Business Wire
Wed, November 20, 2024

Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing™ and Accelerated Data Processing

BRANFORD, Conn., November 20, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing.

This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leveraging NVIDIA accelerated computing and Quantum-Si’s advanced single-molecule protein sequencing and detection technologies, the collaboration aims to develop a robust data processing system. This system will keep pace with Quantum-Si’s rapidly evolving technology advancements, generating single-molecule protein insights to deepen our understanding of the proteome and develop innovative solutions through research, drug discovery, and healthcare AI.

"We are thrilled to collaborate with NVIDIA to make single-molecule proteomics more accessible to researchers," said John Vieceli, Ph.D., Chief Product Officer of Quantum-Si. We have been leveraging AI protein structure prediction tools with NVIDIA BioNeMo, both in the cloud and on-premises to design new and improved biomolecules. Now, we are excited to apply NVIDIA technology for downstream data processing and interpretation applications for Proteus.

"Sequencing proteins to derive insights requires advanced processing capabilities that can handle vast volumes of data," said George Vacek, Global Head of Genomics Alliances at NVIDIA. "Applying NVIDIA technology for accelerated computing and AI, Quantum-Si’s platform for proteomics and multi-omics can make a significant impact on healthcare and life sciences AI and research."

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html

$QSI

Gonna go parabolic and halt

Agree. I have sells at 2.19

QSI: See ME, below, celebratin' already, Peeps!!! (This QSI little puppy gonna end-up today a MECA-GODZILLA-CLASS MONSTER of Wall Street!!!)

///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

Between $1.45- $2.27 has to do a lot of churn next wide zone. All is possible but going to need a lot of volume 
$1.53 + 141%

QSI: I'll take those profits at circa $10-per-share today, Homeboy!!! (O.K., so I just went totally BONKERS!!! Indeed, see me below, live right now!!!)

$1.40 + 120% take profits boom
Boom

QSI: Check-out their NEWS!!!! Are they KIDDING us????
https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html
https://finance.yahoo.com/news/avantor-distribute-quantum-si-next-123000544.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

Bang bang proteins up above $1.45 resistance 
$1.20s + 90%

QSI: I'm in --- who wouldn't be???!!! (Talk about frickin' NEWS hitting the wires!!!!)
https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html
https://finance.yahoo.com/news/avantor-distribute-quantum-si-next-123000544.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

Let's do this QSI!
Bang the shorts

Big week. Coming together nicely. The tech is getting traction and the shorts will get this over $3

Break Out. 10mm short position. 17 days to cover.

Looking strong

QSI new 52 week low

QSI new 52 week low

QSI new 52=week low

From that awful Cathie Wood
Quantum-Si (QSI)
icon-fall
32%
Shares of Quantum-Si traded down ~32% on Monday after the company announced1 second-quarter earnings, including a 19% sequential decrease in revenue. According to management, revenue declined primarily because the company’s new software did not incorporate all the features that some customers had expected and because some customers faced implementation challenges. Quantum-Si is the world’s only provider of protein sequencing instruments, with its core technology based on proprietary time-domain sequencing that enables amino acid level resolution during experiments.

QSI on the verge of a golden cross

Going some more in sympathy with QS

QSI closing in on a golden cross

QSI new rally high

QSI No 6 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

QSI No 10 on the Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

QSI: Despite lovely 'Ms. Awful', QSI is an interesting Firm --- especially its price movements.

QSI that awful Cathie Wood bought over 1million shares for her Ark Genomics etf

QSI to $2.60:
And nobody saw what I saw

Early Barchart Top 100, quote delayed goes real time at 9:45
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
DAL 52/week high
Lot more ahead

QSI now over $2.30

QSI broke $2.20

NSDQ has been on the offer since the run from $1.4. Once he is lifted I see a run to $2.64. Some positive news would be great

QSI at $3.17: